Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 12, 2026
A blockchain-based governance layer for verifiable bid integrity in electricity market clearingFerran Aran, Pablo Fraile, Sambeet Mishra, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 10, 2025
[Epidemiological, clinical, and diagnostic analysis of an outbreak of Parvovirus B19 infection in Mallorca Island]Jordi Reina, Pablo Fraile-Ribot, Julia Viana-Ramírez, et al.
Journal of Environmental Management|September 10, 2017
Measuring geomorphological vulnerability on beaches using a set of indicators (GVI): A tool for managementCarolina Peña-Alonso, Pablo Fraile-Jurado, Luis Hernández-Calvento, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 24, 2026
Implementing Indicator Condition-Guided HIV Screening Alerts in the Emergency Department: Lessons Learned from a Case StudyFrancisco Fanjul, Maria Dolores Macià Romero, Pablo Fraile, et al.
Methodsx|March 30, 2026
A reproducible method to generate multi-building, multi-climate HVAC operation datasets with a stochastic exploratory controllerFerran Aran Domingo, Pablo Fraile Alonso, Josep Rius Torrentó, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 7, 2024
Neonatal SARS-CoV-2 immunoglobulin G antibodies at delivery and their impact on COVID-19Susanne Vetter-Laracy, Victoria Jimenez, Marina Roldán, et al.
BMJ Open Respiratory Research|October 7, 2021
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPDHanaa Shafiek, Javier Verdú, Amanda Iglesias, et al.
Biofilm|November 18, 2024
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilmsMaría Fernández-Billón, Elena Jordana-Lluch, Aina E Llambías-Cabot, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 CloneJorge Arca-Suárez, Pablo Fraile-Ribot, Juan Carlos Vázquez-Ucha, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 27, 2024
Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 PeriodMeritxell Gavalda, Maria Isabel Fullana, Adrià Ferre, et al.
Pageof 2